Esperance Pharmaceuticals' Grant

Esperance Pharmaceuticals raised a round of funding on June 16, 2009. Investors include Qualifying Therapeutic Discovery Project.

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.…

Articles about Esperance Pharmaceuticals' Grant: